Central Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$587K Sell
8,299
-2,945
-26% -$220K 0.01% 419
2025
Q4
$888K Sell
11,244
-445
-4% -$35.2K 0.02% 355
2025
Q3
$963K Buy
11,689
+426
+4% +$33.5K 0.02% 339
2025
Q2
$906K Buy
11,263
+925
+9% +$71.4K 0.02% 337
2025
Q1
$830K Buy
10,338
+1,182
+13% +$98.3K 0.02% 341
2024
Q4
$750K Buy
9,156
+2,135
+30% +$178K 0.02% 355
2024
Q3
$579K Sell
7,021
-54
-0.8% -$4.03K 0.01% 393
2024
Q2
$497K Sell
7,075
-691
-9% -$49.3K 0.01% 405
2024
Q1
$576K Sell
7,766
-492
-6% -$34.3K 0.01% 402
2023
Q4
$546K Sell
8,258
-147
-2% -$9.2K 0.01% 404
2023
Q3
$529K Buy
8,405
+359
+4% +$22.4K 0.02% 399
2023
Q2
$455K Buy
8,046
+131
+2% +$7.27K 0.01% 428
2023
Q1
$459K Sell
7,915
-198
-2% -$13.4K 0.01% 422
2022
Q4
$587K Buy
8,113
+58
+0.7% +$4.15K 0.02% 374
2022
Q3
$490K Buy
8,055
+905
+13% +$57.8K 0.02% 377
2022
Q2
$449K Buy
7,150
+144
+2% +$9.53K 0.01% 392
2022
Q1
$493K Buy
7,006
+551
+9% +$37.3K 0.01% 413
2021
Q4
$404K Buy
6,455
+512
+9% +$32.1K 0.01% 472
2021
Q3
$366K Sell
5,943
-155
-3% -$9.33K 0.01% 461
2021
Q2
$365K Buy
6,098
+250
+4% +$15.8K 0.01% 450
2021
Q1
$355K Sell
5,848
-154
-3% -$8.5K 0.01% 429
2020
Q4
$282K Sell
6,002
-1,292
-18% -$56K 0.01% 441
2020
Q3
$271K Sell
7,294
-1,467
-17% -$55.7K 0.01% 409
2020
Q2
$320K Sell
8,761
-17,984
-67% -$626K 0.02% 384
2020
Q1
$818K Buy
26,745
+15,405
+136% +$683K 0.05% 247
2019
Q4
$578K Sell
11,340
-539
-5% -$26K 0.03% 328
2019
Q3
$560K Sell
11,879
-643
-5% -$30.7K 0.03% 314
2019
Q2
$631K Sell
12,522
-396
-3% -$18.6K 0.04% 300
2019
Q1
$550K Buy
12,918
+409
+3% +$18.1K 0.03% 304
2018
Q4
$513K Sell
12,509
-3,659
-23% -$157K 0.03% 302
2018
Q3
$756K Sell
16,168
-208
-1% -$9.51K 0.04% 275
2018
Q2
$714K Sell
16,376
-2,760
-14% -$129K 0.05% 280
2018
Q1
$878K Sell
19,136
-5,882
-24% -$285K 0.06% 254
2017
Q4
$1.26M Sell
25,018
-851
-3% -$44.8K 0.08% 214
2017
Q3
$1.34M Sell
25,869
-5,001
-16% -$244K 0.09% 199
2017
Q2
$1.51M Sell
30,870
-1,771
-5% -$82.2K 0.1% 183
2017
Q1
$1.54M Buy
32,641
+2,901
+10% +$138K 0.1% 179
2016
Q4
$1.43M Buy
29,740
+1,622
+6% +$74.4K 0.1% 188
2016
Q3
$1.11M Buy
28,118
+2,867
+11% +$108K 0.08% 207
2016
Q2
$896K Sell
25,251
-3,811
-13% -$149K 0.07% 234
2016
Q1
$1.14M Buy
29,062
+236
+0.8% +$8.82K 0.09% 189
2015
Q4
$1.24M Buy
28,826
+1,431
+5% +$62.9K 0.1% 179
2015
Q3
$1.15M Buy
27,395
+5,183
+23% +$242K 0.1% 186
2015
Q2
$1.11M Buy
22,212
+2,410
+12% +$114K 0.09% 203
2015
Q1
$893K Sell
19,802
-11,611
-37% -$522K 0.07% 212
2014
Q4
$1.51M Buy
31,413
+598
+2% +$28.4K 0.12% 156
2014
Q3
$1.48M Buy
30,815
+4,074
+15% +$198K 0.12% 166
2014
Q2
$1.32M Buy
26,741
+2,441
+10% +$114K 0.1% 178
2014
Q1
$1.14M Buy
24,300
+1,422
+6% +$65.4K 0.09% 192
2013
Q4
$1.1M Buy
22,878
+4,845
+27% +$217K 0.09% 191
2013
Q3
$755K Buy
18,033
+3,541
+24% +$153K 0.07% 231
2013
Q2
$591K Buy
+14,492
New +$533K 0.06% 247

Other funds holding MET

Central Trust Company's MET Position: Q1 2026 in Review

Central Trust Company reduced its MetLife (MET) stake by 26% in Q1 2026, selling an estimated $220K and leaving 8,299 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #419.

Central Trust Company first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54M in Q1 2017. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Central Trust Company held 8,299 shares of MetLife worth $587K as of Q1 2026.
  • Central Trust Company sold 2,945 MetLife shares in Q1 2026, an estimated $220K.
  • MetLife made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #419 holding.
  • Central Trust Company first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's MetLife position peaked at $1.54M in Q1 2017.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.